What Is Transcranial Magnetic Stimulation?

Transcranial magnetic stimulation (TMS) is a non-invasive neurostimulation technique that uses rapidly changing magnetic fields to induce localized electrical currents in cortical tissue without requiring electrodes to contact the scalp or skull. A stimulator unit discharges a brief high-current pulse through a coil held against the head; the resulting time-varying magnetic field, typically peaking above 1 Tesla, passes through the scalp and skull with little attenuation and induces a secondary electrical current in the underlying cortex through Faraday's law of electromagnetic induction. This induced current depolarizes neurons in the targeted region, generating action potentials and producing measurable behavioral or physiological effects.

TMS was introduced in its modern form in 1985 by Anthony Barker and colleagues at the University of Sheffield and drew on prior work in peripheral nerve magnetic stimulation. Its non-invasive character, spatial selectivity, and ability to activate or suppress cortical activity with millisecond temporal precision made it immediately valuable for both research and clinical investigation. Unlike electroconvulsive therapy (ECT), which requires anesthesia and produces a generalized seizure, TMS applies stimulation to circumscribed cortical areas in awake, alert subjects.

Electromagnetic Mechanism and Coil Design

The relationship between coil geometry and the spatial distribution of the induced electric field determines TMS focality. The figure-eight coil, formed by two adjacent circular windings with current flowing in opposite directions at the junction, produces a more spatially concentrated electric field than a circular coil and allows targeting of cortical regions to within roughly one centimeter. Deep TMS coils, such as the H-coil design, use more complex winding geometries to reach subcortical structures at the cost of reduced focality.

The induced current penetrates to approximately 2 to 3 centimeters below the scalp surface under standard conditions, limiting direct effects to superficial cortex. Target localization can be improved using stereotaxic neuronavigation systems that register the coil position to the subject's structural MRI, enabling precise, reproducible placement across sessions.

Repetitive TMS and Clinical Therapy

Repetitive transcranial magnetic stimulation (rTMS) applies trains of pulses to produce cumulative effects on cortical excitability that outlast the stimulation session. Low-frequency rTMS at 1 Hz reduces cortical excitability, while high-frequency protocols at 10 to 20 Hz increase it, a dichotomy that maps onto the inhibitory and excitatory after-effects observed in cortical physiology. Theta-burst stimulation (TBS), a compressed protocol delivering bursts of three pulses at 50 Hz repeated at 5 Hz, achieves comparable after-effects in sessions of three minutes compared to the 20 to 40 minutes required by conventional rTMS protocols.

The FDA cleared rTMS for treatment-resistant major depressive disorder in 2008 and for obsessive-compulsive disorder in 2018. Standard depression treatment protocols target the left dorsolateral prefrontal cortex with high-frequency excitatory rTMS over 4 to 6 weeks, typically 20 to 30 sessions. The PMC review of TMS evolution and current applications documents how clinical protocols have standardized around stimulation frequency, intensity relative to motor threshold, pulse count, and inter-session interval.

Research and Diagnostic Applications

Single-pulse and paired-pulse TMS protocols serve as research tools for probing cortical physiology without causing sustained excitability changes. The cortical silent period, the pause in voluntary electromyographic activity following a TMS pulse to the motor cortex, provides a measure of intracortical inhibition. Paired-pulse paradigms using two pulses at controlled intervals reveal short-interval intracortical inhibition (SICI) and intracortical facilitation (ICF), measures linked to GABAergic and glutamatergic interneuron function respectively.

In neurology, TMS measurement of the central motor conduction time provides an objective assessment of corticospinal tract integrity, with diagnostic utility in multiple sclerosis, amyotrophic lateral sclerosis, and cervical myelopathy. NIH's PubMed Central review of TMS in neurological disease treatment summarizes evidence for therapeutic applications spanning stroke, dystonia, and Parkinson's disease. The Mayo Clinic's clinical description of TMS documents the patient experience, safety screening criteria, and contraindications relevant to magnetic implants.

Applications

Transcranial magnetic stimulation is used across clinical, research, and diagnostic contexts, including:

• Treatment of major depressive disorder and obsessive-compulsive disorder refractory to medication
• Mapping of cortical motor and language areas prior to neurosurgical resection
• Diagnosis and monitoring of corticospinal tract function in demyelinating diseases
• Research into cortical plasticity, learning, and the neural basis of cognition
• Investigation of connectivity between cortical areas using TMS combined with EEG or fMRI